| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 113.07B | 103.26B | 95.53B | 94.99B | 85.16B | 103.31B |
| Gross Profit | 31.05B | 28.07B | 25.75B | 24.53B | 23.88B | 44.63B |
| EBITDA | 13.27B | 11.85B | 10.63B | 9.66B | 10.02B | 10.31B |
| Net Income | 26.21B | 5.42B | 2.26B | 1.89B | 4.42B | 4.76B |
Balance Sheet | ||||||
| Total Assets | 167.05B | 123.86B | 120.51B | 111.18B | 103.42B | 92.89B |
| Cash, Cash Equivalents and Short-Term Investments | 16.93B | 10.10B | 9.22B | 8.28B | 6.87B | 6.51B |
| Total Debt | 46.03B | 24.72B | 23.78B | 23.52B | 19.12B | 15.67B |
| Total Liabilities | 71.52B | 44.95B | 46.79B | 43.18B | 37.37B | 32.99B |
| Stockholders Equity | 92.58B | 75.59B | 69.94B | 64.86B | 63.41B | 58.22B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.54B | 2.31B | 935.00M | 48.00M | 2.79B |
| Operating Cash Flow | 0.00 | 9.44B | 9.73B | 8.29B | 8.30B | 8.67B |
| Investing Cash Flow | 0.00 | -7.83B | -8.14B | -8.44B | -9.84B | -6.34B |
| Financing Cash Flow | 0.00 | -1.22B | -1.25B | 972.00M | 1.20B | -257.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥95.10B | 7.83 | ― | 1.47% | 20.44% | 1199.18% | |
66 Neutral | ¥400.28B | 13.58 | 7.90% | 1.95% | 5.82% | -13.40% | |
65 Neutral | ¥381.25B | -38.66 | 1.86% | 1.64% | 8.40% | -23.50% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
62 Neutral | ¥1.07T | 13.62 | 5.97% | 2.96% | 2.79% | -6.46% | |
59 Neutral | ¥427.56B | 10.37 | ― | 2.42% | 2.33% | -8.76% | |
58 Neutral | ¥49.77B | 13.26 | ― | 1.19% | 3.71% | -4.44% |